Philipp F.

Focused on curative and palliative strategies for primary and secondary liver malignancies, the investigator advances surgical resection and ablative techniques for hepatocellular carcinoma and cholangiocarcinoma.

• resection of hepatic tumors
• intra‑operative ultrasound guidance
• portal vein embolization
• multimodal treatment integration

He collaborates closely with oncologists to align surgical interventions with systemic therapies.

He investigates surgical and critical‑care approaches to severe liver dysfunction, including acute liver failure and inherited metabolic disorders such as alpha‑1 antitrypsin deficiency.

• emergency liver transplantation
• hepatic encephalopathy management
• metabolic liver disease assessment
• bridge therapies to transplantation

His contributions aim to reduce mortality in patients with rapid hepatic decompensation.

In the context of post‑transplant care, the investigator addresses complications such as renal allograft dysfunction and pulmonary hypertension associated with interstitial lung disease.

• post‑transplant renal monitoring
• management of transplant‑related hypertension
• diagnosis of bronchiolitis obliterans syndrome
• immune‑mediated graft injury

His research supports early detection and targeted therapies to preserve organ function.

He explores the impact of systemic autoimmune conditions, including systemic lupus erythematosus and systemic sclerosis, on surgical outcomes and graft viability.

• pre‑operative risk stratification
• immunosuppressive regimen optimization
• peri‑operative infection control
• post‑operative inflammatory monitoring

These efforts enhance the safety of complex abdominal and transplant surgeries in vulnerable patient populations.